CXCL2 and neoplasm: Chen et al. assessed the concentrations of CXCL1, CXCL2, CXCL5, CXCL8, CXCL11, and CXCL13 in tumor drainage blood and peripheral blood from relapse-free GC patients and found that post-treatment levels were lower in comparison to pre-treatment concentrations [16].